36C24220Q0809_1.docx

DOCX document 25 KB Posted

Attached to
3650--Albany Radiopharmaceuticals - Nuclear Medicine
Solicitation number
36C24220Q0809
Issued by

View the file

Other files

File Type Posted
RFQ - 36C24220Q0809 - Radiopharmaceuticals for Albany VAMC.docx DOCX document

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Contract Opportunity Combined Synopsis/Solicitation Notice

PRODUCT SERVICE CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

RESPONSE DATE/TIME/ZONE

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

SET-ASIDE

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

GENERAL INFORMATION

PLACE OF PERFORMANCE

* = Required Field Contract Opportunity Combined Synopsis/Solicitation Notice Albany Radiopharmaceuticals - Nuclear Medicine 14424 36C24220Q0809 08-12-2020

4 PM

EASTERN TIME, NEW YORK, USA

N 325412 Department of Veterans Affairs 400 Fort Hill Ave.

Canandaigua NY 14424

Description This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, “Streamlined Procedures for Evaluation and Solicitation for Commercial Items,” as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued.

This solicitation is issued as an RFQ. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2020-07

This solicitation is for Full and Open Competition

The associated North American Industrial Classification System (NAICS) code for this procurement is 325412, with a small business size standard of 1000 employees.

The FSC/PSC is 3650.

The Albany VA Medical Center, 113 Holland Avenue, Albany, NY 12208 has a requirement for a United States Nuclear Regulatory Commission (US NRC) and Food and Drug Administration (FDA) Licensed Contractor to provide radiopharmaceuticals for the Nuclear Medicine Department for patient care.

All interested companies shall provide quotations for the following:

Supplies/Services Statement of Work Radiopharmaceuticals

1.0 SCOPE

The Department of Veterans Affairs Stratton VA Medical Center (VAMC) located at 113 Holland Avenue, Albany, NY 12208 has a requirement for a United States Nuclear Regulatory Commission (US NRC) and Food and Drug Administration (FDA) Licensed Contractor to provide radiopharmaceuticals for the Nuclear Medicine Department for patient care. The Albany VAMC intends to award a base year plus two option years, firm fixed price, Requirements Contract to a licensed Radiopharmacy authorized to manufacture and distribute Radiopharmaceutical Supplies and Services in New York State with a period of performance of October 1, 2020 through September 30, 2023. The Contractor agrees in accordance with the terms and conditions stated herein, to furnish Radiopharmaceuticals in accordance with Federal, State, and Local Regulations. The Contractor shall be able to provide all of the items listed in the Schedule of Radiopharmaceuticals with deliveries when required. Multiple awards will not be made.

1.1 BACKGROUND

The Stratton VAMC is responsible for providing high quality and timely commodities and services for our Veterans. One area to serve our Veterans is to ensure that the best possible medical supplies are both timely and in accordance with proper regulations with Contractors that are licensed and monitored according to Federal, State, and Local Regulations. Under the Atomic Energy Act, the US NRC is responsible for regulating uses of radioactive material, including radio pharmaceuticals. The US NRC requires all nuclear medicine facilities to be licensed. The license assures that the facility has a radiation protection program to protect both the patients and the staff. In addition, the staff must meet certain standards of training and experience before they are allowed to administer radioactive material to patients. Each state has one or more radiation programs that ensure the safe use of radioactive materials. The US NRC has transferred regulatory authority over the use of this material to 35 NRC Agreement States. In these states, the regulatory authority inspects the facility to ensure the staff is trained properly and the equipment is operating safely. FDA’s Center for Drug Evaluation and Research regulates the radio pharmaceuticals, ensuring effectiveness and patient safety. The mission of The National Institute of Standards and Technology (NIST) is to develop and promote measurement, standards, and technology to enhance productivity, facilitate trade, and improve the quality of life.

2.0STATEMENT OF WORK
1.The Contractor agrees to provide all listed radiopharmaceuticals as identified in the Schedule of Radiopharmaceuticals to the Stratton VAMC on a daily or as needed basis in accordance with this Statement of Work. Because of the critical need for these supplies in a timely manner, only Contractors that can deliver within two hours to the Stratton VAMC need to respond to this solicitation. Time is of the essence for all deliveries. These delivery timeframes are absolutely critical to ensure proper patient care and safety. The two-hour timeframe shall include the following: order processing, compounding order, travel, locating parking at the Medical Center, and delivery of radiopharmaceuticals to Radiology. The Contractor shall be licensed by the State of New York or another agreement state approved by the Nuclear Regulatory Commission and shall be regularly established in the business of providing radionuclides in accordance with New York State regulations. The Contractor shall provide evidence of delivery in less than 2 hours with their proposal. The Contractor shall identify the location of the point of shipment to the address listed in the first paragraph of this solicitation. Verification will be completed via www.mapquest.com.
2.Deliveries will incorporate sufficient lead or other high-density metal shielding to comply with all applicable Federal, State, and Local standards relating to shipment of radioactive materials. Shipping containers must comply with all Federal and State regulations. This will include the FDA, DOT, DOE, USNRC, and ICC regulations and standards. Documentation of US DOT package integrity testing shall also be provided with each delivery.
3.Items must be adequately packaged to prevent damage during handling and storage. All packaging and labeling must meet all Federal, State, and Local regulations. All packaging of radioactive material must be clearly labeled “RADIOACTIVE” on the outside of the carton in which it is shipped.
4.The Contractor shall label all products delivered to the Stratton VAMC with the radiopharmaceutical, activity, time of preparation, and expiration time and date.
5.The Contractor shall hold a current unrevoked NRC or an agreement state radioactive materials license, which in addition to other license conditions, would allow for the receipt and disposal of radioactive material, as well as an FDA license to produce and distribute radiopharmaceuticals for human administration. The Contractor shall provide a copy of their radioactive material license with their proposal. The Contractor shall immediately notify the Contracting Officer (CO) and the Contracting Officer Representative (COR), upon any action by the NRC or an agreement state or the FDA to suspend or modify their radioactive materials license. The Contractor shall provide radiopharmaceuticals which have been prepared according to manufacturer’s package inserts and applicable FDA requirements. The Contractor shall perform all quality control procedures as required by Federal and State Regulatory Agencies.
6.The Contractor will provide with their proposal all of the following information for paragraphs a through d:
a.The Contractor’s regular work hours.
b.The Contractor’s telephone number for call-in orders during regular work hours.
c.The Contractor’s telephone number and instructions for placing Emergency orders after the Contractor’s regular work hours to include weekends.
d.The Contractor’s telephone number for expert advice concerning awarded products.
e.The Contractor will furnish a statement that any radiopharmaceuticals delivered as “ready-to-use” (individual doses in syringes or vials for single or multiple uses) will have quality control performed by the Contractor, so that the delivered product will comply with the requirements of the Joint Commission (JC) and with the United States Pharmacopeia.
f.Should any changes occur in the above information during the contract period of performance the Contractor will immediately provide all applicable updates in writing to the CO and COR.
7.Current package inserts of all radiopharmaceuticals supplied under the awarded contract will be shipped to the Nuclear Medicine Service at the inception of the contract. If any new or updated additions to the package inserts are made available, these will be sent to the COR at the Stratton VAMC Nuclear Medicine Department.
8.The Contractor shall make quality control records available upon written request from the CO or COR.
9.The Contractor shall test all products for Quality Control periodically. This testing shall be performed at no cost to the Government. The Contractor shall provide a detailed description of the test results when requested.
10.The calibration time for each requested radiopharmaceutical shall be provided in the Schedule of Radiopharmaceuticals as part of the Contractor’s proposal pricing.
11.If an ordered dosage of radioactive material is given to the Contractor such that it is to fall within a specified range, then the quantity of radioactivity must be within the dose range provided. If dose is not given in a range, then the quantity of radioactivity for supplied radiopharmaceuticals will not deviate more than ±20%.
12.Technetium product radiopharmaceuticals not used will be returned for credit the next workday (including the bulk doses), using the DOT regulations. Credit will be reflected in the current month’s invoice.
13.The Contractor shall replace any items delivered damaged or in error at no cost to the Government. The COR shall define the replacement date and time. Replacements may be required immediately or within a specified time in accordance with patient needs.
14.The expiration date and time shall be indicated and affixed to each product as noted below; in general:
a.Ready-to-use doses: not shorter than six (6) hours.
b.Tc-99m pertechnetate: Not shorter than twelve (12) hours.
c.Kits intended for reconstitution by user: Not shorter than three (3) months from date of delivery.
d.Unused kits having expiration time not less than two (2) weeks will be exchanged by the Contractor at no additional charge for a comparable kit having the three (3) months life span.
15.In the event that a quality control or material defect is suspected or detected by the COR, the Contractor will be requested to provide any consultation necessary to alleviate any said suspicion or defect by the following:
a.Provide technical expertise in calibration.
b.Provide professional examination of product. Submit results and recommendations to the COR.
c.Make expedient replacement of any product suspected of being deficient.
16.Approximately five (5) times per year, the below procedures are to be followed for labeling of patient's white blood cells (WBC) with Indium-111 Oxine or Tc-Ceretec, for re-injecting to the same patient:
a.Telephone requests to the Contractor to arrange for the procedure will take place no later than 3:30 PM for the next workday procedure.
b.The Contractor shall be at the Nuclear Medicine Department no later than 8:30 AM to pick up the patient's blood specimen for labeling.
c.The return by the Contractor, of the patient's Indium or Tc-Ceretec labeled white blood cells will take place no more than 5 (five) hours from the time of specimen pick up time.
d.Pertinent documentation confirming that the identification of the labeled blood specimen matches with the blood specimen of the patient's blood specimen submitted for labeling procedure.
17.The Contractor shall pick up radiopharmaceuticals (used and unused) for proper disposal at no cost to the Government.
18.The Contractor shall produce radiopharmaceuticals as described in the Schedule of Radiopharmaceuticals.

3.0 Deliverables and Acceptance Criteria

1.The Contractor shall provide services and staff, and otherwise do all things necessary for or incidental to the Statement of Work, as set forth below:
a.Provide up to two deliveries per day during regular operating hours to the Stratton Nuclear Medicine Service at no additional charge. The delivery charge for emergency orders to be included on the Schedule of Radiopharmaceuticals. The Delivery charge for STAT orders is to be included on the Schedule of Radiopharmaceuticals. STAT deliveries will average, three (3) times a week.
b.Deliver directly to the Stratton Nuclear Medicine Service daily quantity of radiopharmaceuticals by 7:00 AM, as requested from the previous workday by 4:00 PM, unless otherwise noted as an emergency, requiring a two-hour turnaround time.
c.Second daily delivery, if necessary, must be delivered no later than 11:00 AM.
d.Orders can be placed orally by telephone by Ordering Officers provided by the COR.
e.Deliver directly to the Nuclear Medicine Service at the Stratton VAMC, the quantity of radiopharmaceutical requested on an emergency basis to arrive in less than two (2) hours after notification.
f.Radioactive dose boxes that are delivered outside of working hours will be delivered to Nuclear Medicine. The Contractor shall not leave a radioactive materials package at the Stratton VAMC unless they have verbally communicated with a Nuclear Medicine staff member.
g.Other delivery times may be outlined by the Stratton VA Medical Center in this Statement of Work.
2.On Federal Holidays, no normal deliveries will be expected. If Monday is a Federal Holiday, no deliveries will be expected. Holidays are listed under 4.0 VA Operating Hours.
3.Emergency deliveries may be requested at any time outside normal delivery times, including weekends, holidays, and nights.
4.Shipments requested as an Emergency will be delivered as follows:
a.Requests placed after regular work hours (weekends, holidays, and nights) will be delivered within two (2) hours, or as specified.
b.Emergency, weekend, and holiday deliveries are to be delivered to location(s) specified by the Stratton VA Nuclear Medical Department, unless otherwise specified when called for.
c.Emergency deliveries will be required within two (2) hours after the order is placed.
d.All shipments will be labeled as “RADIOACTIVE MATERIAL” in compliance with all pertinent regulations.
e.All Radiopharmaceuticals, Radioassay Kits, and Analytic Kits are to be furnished by the Contractor in strict accordance with the terms and conditions of the contract and all applicable Federal, State, and Local Laws.
f.Delivery dates, times, frequency of deliveries, specific dosages, and all other specific requirements by the Stratton VAMC in this Statement of Work will be strictly adhered to.
5.All shipments must have a Packing Slip enclosed, giving information about the product and its identification, plus (for billing purposes) the Stratton VAMC Purchase Order Number issued for the current fiscal year, and the Contractor’s invoice number. Providing incorrect Purchase Order numbers on invoices will cause a substantial delay in payments to the Contractor.

4.0 VA OPERATING HOURS

The delivery of products provided by the respective awarded contract shall be furnished by the Contractor in accordance with section 3.0 Deliverables and Acceptance Criteria. The Contractor shall not be required, except in case of an emergency, to furnish such products on a national holiday or during non-working hours as described below with the exception of normal next day delivery.

The following terms have the following meanings:

Normal Operating hours of Nuclear Medicine: Monday through Friday, 7:00 AM to 4:00 PM Eastern Standard Time Normal deliveries shall be accomplished at 7:00 AM and 11:00 AM. The Contractor to include up to two (2) deliveries per normal working day during normal working hours as needed at no additional charge.

National Holidays: The ten (10) holidays observed by the Federal Government are as follows:

New Year's Day, Martin Luther King's Birthday, President’s Day, Memorial Day, Independence Day, Labor Day, Columbus Day, Veteran's Day, Thanksgiving, and Christmas, and any other day specifically declared by the President of the United States to be a national holiday.

5.0 CONTRACT AWARD

Upon Contract Award (within five (5) business days) the awarded Contractor shall provide:

1.A copy of their Laboratory’s current quality control manual to the COR.
2.A dedicated inside sales representative to aide in facilitation in the smooth coordination between the Stratton VA Medical Center and the Contractor’s Laboratory Pharmacy.
3.Material safety data sheets and updates on all delivered products as per contract award to include any additions throughout the period of performance of the awarded contract.
4.Patient orientation education video presentations and other appropriate material at no additonal cost to the Government.
5.The Contractor shall provide signs and posters alerting patients, employees and the public, of safety precautions in the handling of radioactive materials.

6.0 QUALITY REQUIREMENTS

The Contractor shall guarantee the quality of their radiopharmaceuticals. Quality Control (QC) shall include pH testing, percent tag, alumina, and 99Mo breakthrough as appropriate. Quality Control shall be performed on each agent dispensed. Complete documentation of QC results will be provided upon request. All radiopharmaceuticals shall be calibrated and labeled with concentration, time, total volume, and total activity. Consultation service regarding radiopharmaceutical applications, problems, controls, shall be provided upon request at no charge. On an annual basis, the Contractor shall provide documentation demonstrating compliance with applicable agreement state or NRC license requirements to the Radiation Safety Officer or COR.

7.0 PERSONNEL POLICY

The Contractor is responsible for all costs, including personnel costs, associated with the awarded contract, unless otherwise specified.

Qualifications - Personnel assigned by the Contractor to prepare and provide the products covered within this Statement of Work shall be Nuclear Pharmacists or a Licensed Technologist working under the supervision of a Nuclear Pharmacist licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia.

8.0 SPECIAL CONTRACT REQUIREMENTS: HHS/OIG

To ensure that the individuals providing services under the respective awarded contract have not engaged in fraud or abuse regarding Sections 1128 and 1128A of the Social Security Act regarding Federal Health Care Programs, the Contractor is required to check the Health and Human Services - Office of Inspector General (HHS/OIG), List of Excluded Individuals/Entities on the OIG Website for each person providing services under the respective awarded contract. The listed parties and entities may not receive Federal Health Care program payments due to fraud or abuse of the Medicare and Medicaid programs. During the period of performance of the respective awarded contract the Contractor is prohibited from using any individual or business listed on the List of Excluded Individuals/Entities. Any healthcare provider or entity that employ or enter into contracts with excluded individuals or entities may have a Civil Monetary Penalty imposed against them. By signing their proposal, the Contractor certifies that all persons or entities listed in the Contractor’s proposal have been compared against the OIG list and are not listed as of the date their proposal was signed.

9.0 CONTRACTOR STAFF ROLES AND RESPONSIBILITIES

The Contractor must be in compliance with all Nuclear Regulatory Commission, United States Pharmacopeia, United States Food and Drug Administration, State, Local and Joint Commission guidelines, as well as United States Pharmacopeia 797 guidelines.

10.0 CONTRACTOR PERFORMANCE ASSESSMENTS (CPARS)

Assessments: The Government will complete assessments of the Contractor’s performance. The Contractor shall have an opportunity to respond to said assessments.

Record: The Government will keep completed assessments that will serve as past performance data. Past performance data will be available to assist agencies in the selection of radio-pharmacy Contractors for future contracts.

11.0 DESIGNATION OF CONTRACT OFFICER REPRESENTATIVE (COR)

The COR will be designated in writing. The COR will be furnishing technical guidance and advice regarding the work being performed under the respective awarded contract. The foregoing is not to be construed as authorization to interpret or furnish advice and information to the Contractor relative to the financial or legal aspects of the respective awarded contract. Enforcement of these segments is vested in and is the responsibility of the Contracting Officer.

12.0 CONTRACTOR RECALL AND SAFETY PLAN AND PROCESS NOTIFICATION TO FACILITY

The Contractor shall take immediate action to notify the COR whenever a product, piece of equipment or item is recalled or considered dangerous, hazardous or unsafe in order to remove such products, equipment or items from use. This notification process also applies to safety alerts. The Contractor recall and safety notification plan and process are necessary so that proper notification to individuals who have received or individuals who may utilize such products, equipment or items can be made in an expedient and efficient manner as possible. The Contractor shall provide to the COR their plan for this safety notification process and maintain a record system in order to document any safety incident issues by their date, time, and description of the recall or safety alert issue provided to the COR.

13.0 HIPAA COMPLIANCE

The Contractor must adhere to the provisions of Public Law 104-191, Health Insurance Portability and Accountability Act (HIPAA) of 1996 and the National Standards to Protect the Privacy and Security of Protected Health Information (PHI). As required by HIPAA, the Department of Health and Human Services (HHS) has promulgated rules governing the security and use and disclosure of protected health information by covered entities, including the Department of Veterans Affairs (VA).

14.0 AVAILABILITY OF FUNDS DURING A CONTINUING RESOLUTION

At the beginning of each new fiscal year (1 October) the Federal Government or parts thereof may be operating under a Continuing Resolution (CR) and only be funded for a limited period of time rather than for the entire fiscal year. If at any time funds for this contract are provided under a CR, funds will only be available for performance under the respective awarded contract up to and including the expiration date of the CR, and any extension thereof. The Government's obligation for performance of the respective awarded contract beyond that date is contingent upon the availability of appropriated funds from which payment for contract purposes can be made. No legal liability on the part of the Government for any payment may arise for performance under the respective awarded contract beyond the expiration date of the CR, and any extension thereof, until funds are made available to the Contracting Officer for performance and until the Contractor receives notice of availability.

15.0 REQUIRED REGISTRATION WITH CONTRACTOR PERFORMANCE ASSESSMENT SYSTEM (CPARS)

As prescribed in Federal Acquisition Regulation (FAR) Part 42.15, the Department of Veterans Affairs (VA) evaluates Contractor past performance on all contracts that exceed the thresholds outlined in FAR Part 42.15, and shares those evaluations with other Federal Government Contracting Specialists and procurement officials through the Past Performance Information Retrieval System (PPIRS). The FAR requires that the Contractor be provided an opportunity to comment on past performance evaluations prior to the posting of each report. To fulfill this requirement VA uses an online database, the Contractor Performance Assessment Reporting System (CPARS). The CPARS database information is uploaded to the Past Performance Information Retrieval System (PPIRS) database, which is available to all Federal agencies. Each Contractor whose contract award is estimated to exceed the thresholds outlined in FAR Part 42.15 is required to provide to the Contracting Officer contact information for the Contractor’s representative with their response to the solicitation. The Contractor is responsible to notify the Contracting Officer of any change to the Contractor’s representative during the contract period of performance. The Contractor’s representative contact information consists of their name, telephone number, and email address.

The Government will register the respective awarded contract within thirty (30) days after contract award. For contracts exceeding one (1) year, the Contracting Officer will evaluate the Contractor’s performance annually. Intermediate reports will be filed each year until the last year of the contract, when the final report will be completed. Each report shall be forwarded in CPARS to the Contractor’s designated representative for comment. The Contractor’s representative will have thirty (30) days to submit any comments and return the report to the VA Contracting Officer. Failure by the contractor to respond within those thirty (30) days will result in the Government’s evaluation being placed on file in PPIRS without contractor’s comments.

16.0 PROHIBITION (WORKING OUTSIDE OF US)

The entire performance of the respective awarded contract shall be within the borders of the United States of America. The Contractor shall not access any Department of Veterans Affairs data information (for example, by remote computer access) from locations that are outside the above-stated borders. Furthermore, the Contractor shall not send, transfer, mail, or otherwise transmit any Department of Veterans Affairs data or information to locations outside the above-stated borders.

17.0 CONTRACT TERM

The respective awarded IDIQ contract shall be for one (1) base year and two (2) option years. The base year period of performance is from October 1, 2020 through September 30, 2021. Option year one (1) period of performance is from October 1, 2021 through September 30, 2022. Option year two (2) period of performance is from October 1, 2022 through September 30, 2023.

18.0 Schedule of Radiopharmaceuticals

Please Note: Your proposal must provide pricing on ALL items in the Schedule of Radiopharmaceuticals Required and all four columns must be filled in with your proposal.

Prices quoted are all inclusive including all associated costs including shipping, handling, packaging, storage, licenses etc. excluding emergency delivery, Pharmacist After-Hour Emergency Call-Back and Weekend White Blood Cell labeling charge.

CLINRadiopharmaceuticalUnit of MeasureQtySizePrice For Each mCi or BulkTotal PriceNumber of Minutes Needed to Prepare Product at RadiopharmacyNDC Of Offered Product
0001Tc99m (Bulk) PertechnetateBulk dose4250 mCi
0002CardioliteUnit dose40030mCi
0003CardioliteUnit dose40010mCi
0004MAAUnit dose306mCi
0005DTPAUnit dose4075mCi
0006MDPUnit dose9025mCi
0007Sulfur Colloid (Liver/ Spleen or gastric emptying)Unit dose206mCi
0008Tc99m Pertechnetate (MUGA/Hemangioma )Unit dose3025mCi
0009CholetecUnit dose256mCi
0010PYP (MUGA/Hemangioma)Unit dose301 Vial
0011Mag-3Unit dose2010mCi
0012Certec WBCStudy1010-30mCi
0013OctreotideUnit dose106mCi
0014I-123 200’sCaps40200mCi
0015I-131 Therapy/Whole Body 1 – 6 mCi)Caps5Up to 6mCi
0016I-131 Therapy (per mCi)Caps5Up to 6mCi
0017Thallium 201Unit dose15mCi
0018Gallium 67Unit dose110mCi
0019Sulfur Colloid (filtered)Unit dose15250uCi
0020Thallium 201 BrainUnit dose45mCi
0021Tc99m Pertechnetate Meckel’s Thyroid ImagingUnit dose110mCi
0022Cardiolite (Parathyroid)Unit dose1525mCi
0023Ceretec Brain (Brain Imaging)Unit dose330mCi
0024Sulfur Colloid (gastric emptying)Unit dose201mCi
0025Tc99 Pertechnetate (hemangioma)Unit dose1025mCi
0026PYP (hemangioma)Unit dose101 Vial
0027Tc99m Pertechnetate (Thyroid Imaging)Unit dose510mCi
0028Thallium 201 (stress cardiac)Unit dose54mCi
0029DATSCAN I-123 Ioflupane1 Vial53 -5mCi
0030Quadramet TherapyUnit1
0031Emergency order fee to include Pharmacist preparation and deliveryDeliveryApprox. 3 per week. Estimate156 AnnuallyOrder
CLINRadiopharmaceuticalUnit of MeasureQtySizePrice For Each mCi or BulkTotal PriceNumber of Minutes Needed to Prepare Product at RadiopharmacyNDC Of Offered Product
1001Tc99m (Bulk) PertechnetateBulk dose4250mCi
1002CardioliteUnit dose40030mCi
1003CardioliteUnit dose40010mCi
1004MAAUnit dose306mCi
1005DTPAUnit dose4075mCi
1006MDPUnit dose9025mCi
1007Sulfur Colloid (Liver/ Spleen or gastric emptying)Unit dose206mCi
1008Tc99m Pertechnetate (MUGA/Hemangioma)Unit dose3025mCi
1009CholetecUnit dose256mCi
1010PYP (MUGA/Hemangioma)Unit dose301 Vial
1011Mag-3Unit dose2010mCi
1012Certec WBCStudy1010-30mCi
1013OctreotideUnit dose106mCi
1014I-123 200’sCaps40200mCi
1015I-131 Therapy/Whole Body 1 – 6mCi)Caps5Up to 6mCi
1016I-131 Therapy (per mCi)Caps5Up to 6mCi
1017Thallium 201Unit dose15mCi
1018Gallium 67Unit dose110mCi
1019Sulfur Colloid (filtered)Unit dose15250uCi
1020Thallium 201 BrainUnit dose45mCi
1021Tc99m Pertechnetate Meckel’s Thyroid ImagingUnit dose110mCi
1022Cardiolite (Parathyroid)Unit dose1525mCi
1023Ceretec Brain (Brain Imaging)Unit dose330mCi
1024Sulfur Colloid (gastric emptying)Unit dose201mCi
1025Tc99 Pertechnetate (hemangioma)Unit dose1025mCi
1026PYP (hemangioma)Unit dose101 Vial
1027Tc99m Pertechnetate (Thyroid Imaging)Unit dose510mCi
1028Thallium 201 (stress cardiac)Unit dose54mCi
1029DATSCAN I-123 Ioflupane1 Vial53-5mCi
1030Quadramet TherapyUnit1
1031Emergency order fee to include Pharmacist preparation and deliveryDeliveryApprox. 3 per week. Estimate156 AnnuallyOrder

Option Year Two (October 1, 2022 through September 30, 2023)

CLINRadiopharmaceuticalUnit of MeasureQtySizePrice For Each mCi or BulkTotal PriceNumber of Minutes Needed to Prepare Product at RadiopharmacyNDC Of Offered Product
2001Tc99m (Bulk) PertechnetateBulk dose4250mCi
2002CardioliteUnit dose40030mCi
2003CardioliteUnit dose40010mCi
2004MAAUnit dose306mCi
2005DTPAUnit dose4075mCi
2006MDPUnit dose9025mCi
2007Sulfur Colloid (Liver/ Spleen or gastric emptying)Unit dose206mCi
2008Tc99m Pertechnetate (MUGA/Hemangioma)Unit dose3025mCi
2009CholetecUnit dose256mCi
2010PYP (MUGA/Hemangioma)Unit dose301 Vial
2011Mag-3Unit dose2010mCi
2012Certec WBCStudy1010-30mCi
2013OctreotideUnit dose106mCi
2014I-123 200’sCaps40200mCi
2015I-131 Therapy/Whole Body 1 – 6mCi)Caps5Up to 6mCi
2016I-131 Therapy (per mCi)Caps5Up to 6mCi
2017Thallium 201Unit dose15mCi
2018Gallium 67Unit dose110mCi
2019Sulfur Colloid (filtered)Unit dose15250uCi
2020Thallium 201 BrainUnit dose45mCi
2021Tc99m PertechnetateUnit dose110mCi
2022Cardiolite (Parathyroid)Unit dose1525mCi
2023Ceretec Brain (Brain Imaging)Unit dose330mCi
2024Sulfur Colloid (gastric emptying)Unit dose201mCi
2025Tc99 Pertechnetate (hemangioma)Unit dose1025mCi
2026PYP (hemangioma)Unit dose101 Vial
2027Tc99m Pertechnetate (Thyroid Imaging)Unit dose510mCi
2028Thallium 201 (stress cardiac)Unit dose54mCi
2029DATSCAN I-123 Ioflupane1 Vial53- 5mCi
2030Quadramet TherapyUnit1
2031Emergency order fee to include Pharmacist preparation and deliveryDeliveryApprox. 3 per week. Estimate156 AnnuallyOrder

After hour/Emergency charges – Stratton VA Medical Center Deliveries during normal work hours (Monday - Friday) at no charge. Offeror (s) may list any additional charges below:

Deliveries during normal business hoursDay: No Charge
Emergency Delivery1Each:
Pharmacist After-Hour Emergency Call-Back2Each:
Weekend White Blood Cell labeling charge3Each:

Emergency Delivery: Charge for delivering unscheduled Emergency orders during normal business hours within two (2) hours of receiving the order by phone from the Stratton VA Medical Center Nuclear Medicine Department.

Pharmacist (Emergency after hours): The charge for having a Pharmacist called back to the Pharmacy after hours, prepare the ordered dose and have it delivered to the VA within two hours. (Emergency orders only).

Weekend WBC labeling charge: The charge for the pharmacy to attach a radionuclide to the patient’s white blood cells on a weekend.

The contract period of performance is October 1, 2020 through September 30, 2023.

Place of Performance/Place of Delivery Address: Albany VA Medical Center 113 Holland Ave.

Albany, New York

Postal Code:12208
Country:UNITED STATES

The full text of FAR provisions or clauses may be accessed electronically at http://acquisition.gov/comp/far/index.html.

The following solicitation provisions apply to this acquisition:

1.FAR 52.212-1, “Instructions to Offerors–Commercial Items”
2.FAR 52.212-3, “Offerors Representations and Certifications–Commercial Items”

Offerors must complete annual representations and certifications electronically via the System for Award Management (SAM) website located at https://www.sam.gov/portal in accordance with FAR 52.212-3, “Offerors Representations and Certifications–Commercial Items.” If paragraph (j) of the provision is applicable, a written submission is required.

The following contract clauses apply to this acquisition:

• FAR 52.212-4, “Contract Terms and Conditions–Commercial Items” [Oct 2008]

• FAR 52.212-5, “Contract Terms and Conditions Required to Implement Statutes or Executive Orders” [June 2020]

All quotes shall be sent to the Contracting Officer: Sam DeMuzio, sam.demuzio@va.gov

Award will be based upon a comparative evaluation of quotes in accordance with the Simplified Acquisition Procedures of FAR 13. Comparative evaluation is the side by side pairwise comparison of quotes based on factors resulting in a Contracting Officer decision for the quote most favorable to the Government.

The following are the decision factors:

Technical, Past Performance and Price

The award will be made to the response most advantageous to the Government.

Responses should contain your best terms, conditions.

To facilitate the award process, all quotes must include a statement regarding the terms and conditions herein as follows:

"The terms and conditions in the solicitation are acceptable to be included in the award document without modification, deletion, or addition."

OR

"The terms and conditions in the solicitation are acceptable to be included in the award document with the exception, deletion, or addition of the following:"

Quoters shall list exception(s) and rationale for the exception(s), if any.

Submission of your response shall be received not later than August 12, 2020, 4:00 pm at sam.demuzio@va.gov.

Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f).

Any questions or concerns regarding this solicitation should be forwarded in writing via e-mail to the Point of Contact listed below.

Point of Contact Sam DeMuzio Contracting Officer Sam.demuzio@va.gov See attached document: RFQ - 36C24220Q0809 - Radiopharmaceuticals for Albany VAMC.

File details come from the government source that posted it. Updated .